Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Active Symptom Control Alone or With mFOLFOX Chemotherapy for Locally Advanced/ Metastatic Biliary Tract Cancers (ABC06)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by The Christie NHS Foundation Trust
Sponsor:
Collaborator:
Cancer Research UK
Information provided by (Responsible Party):
Safia Barber, The Christie NHS Foundation Trust
ClinicalTrials.gov Identifier:
NCT01926236
First received: August 17, 2013
Last updated: August 3, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2018
  Estimated Primary Completion Date: January 2018 (Final data collection date for primary outcome measure)